All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @thetamsenshow on TikTok · 109s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @thetamsenshow's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00A lot of women are telling, they're coming up saying like, I'm feeling great.
  2. 0:03My sex life is back.
  3. 0:03I'm doing pellets.
  4. 0:05And then I'll talk to somebody else that said I did them, but I got too much testosterone.
  5. 0:09So can you explain that?
  6. 0:10If there are pros and cons or just cons or pellets are a drug delivery method that is
  7. 0:16implanted usually around the buttock really small, like a piece of bird seed.
  8. 0:20It's the most expensive way to get hormones and it's the highest dose way to get hormones.
  9. 0:24And to me, I'm especially if you're introducing yourself to hormones.
  10. 0:28That's not ideal, right?
  11. 0:31I always say you have to earn your pellet.
  12. 0:33What do I mean by that?
  13. 0:34Know that you tolerate hormones, you tolerate them at lower doses, that you work your way
  14. 0:39up to higher doses.
  15. 0:41And then so who's the perfect pellet person?
  16. 0:44I tolerate hormones.
  17. 0:45I actually feel better at higher doses.
  18. 0:47I'm not getting side effects.
  19. 0:48I have the money that I can do this for the next 40 years.
  20. 0:52And I like plug and play where I just have to think about this four times a year because
  21. 0:55it's a longer acting.
  22. 0:57There are two schools.
  23. 0:59There's like the pellet only people.
  24. 1:01Then there's the we should ban pellet people.
  25. 1:03To me, I think it should be on the menu.
  26. 1:06Like it's your most expensive bottle of wine.
  27. 1:09That is not what everybody needs.
  28. 1:11It's not practical and it's the highest dose.
  29. 1:15And what we know again, let's use our wonderful trans data because we have it.
  30. 1:19It takes a while to start seeing to higher level testosterone side effects.
  31. 1:23I don't give you a high dose.
  32. 1:25You look more burly tomorrow.
  33. 1:28It's slow.
  34. 1:29And in the women that continue to take the pellets, I worry about their
  35. 1:34androgenic side effects over time.
  36. 1:37Sure. Not everybody will get that.
  37. 1:39But that's what I worry about with higher doses.
  38. 1:41Like eh, testosterone at 250 for a while.
  39. 1:44Do that for a couple of years.
  40. 1:46That's real.
  41. 1:47There might be some things you might not like, but you don't know that right away.

@thetamsenshow's testosterone therapy claims, fact-checked

thetamsenshow

TikTok creator

61.2K viewsWatch on TikTok

Quick answer

Testosterone pellets in women consistently produce supraphysiologic serum levels compared to transdermal and injectable formulations, with limited ability to reduce dosing once implanted. The creator's caution about cumulative androgenic exposure is supported by Endocrine Society guidelines and observational data from transgender men, though direct prospective studies in cisgender women on pellet therapy remain limited. Patients new to testosterone therapy should establish tolerability at lower, adjustable doses before committing to a pellet implant.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @thetamsenshow's testosterone therapy claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

@thetamsenshow's testosterone therapy claims, fact-checked should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@thetamsenshow's testosterone therapy claims, fact-checked" from thetamsenshow. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Testosterone pellets in women consistently produce supraphysiologic serum levels compared to transdermal and injectable formulations, with limited ability to reduce dosing once implanted.

The reason this review is not generic is the source wording and the canonical claim label "trt thetamsenshow testosterone hormonetherapy." In this clip, the useful excerpt is: "A lot of women are telling, they're coming up saying like, I'm feeling great." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Once implanted, pellets cannot be dose-adjusted for three to six months, which makes them poorly suited for patients who have not established testosterone tolerability.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Testosterone pellets in women consistently produce supraphysiologic serum levels compared to transdermal and injectable formulations, with limited ability to reduce dosing once implanted.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Testosterone pellets in women consistently produce supraphysiologic serum levels compared to transdermal and injectable formulations, with limited ability to reduce dosing once implanted. The creator's caution about cumulative androgenic exposure is supported by Endocrine Society guidelines and observational data from transgender men, though direct prospective studies in cisgender women on pellet therapy remain limited. Patients new to testosterone therapy should establish tolerability at lower, adjustable doses before committing to a pellet implant.
  • Testosterone pellets in women produce supraphysiologic serum levels in most patients, often two to four times higher than transdermal formulations, per Davis et al. (2019, Climacteric).
  • Once implanted, pellets cannot be dose-adjusted for three to six months, which makes them poorly suited for patients who have not established testosterone tolerability.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Testosterone pellets in women produce supraphysiologic serum levels in most patients, often two to four times higher than transdermal formulations, per Davis et al. (2019, Climacteric).
  • Once implanted, pellets cannot be dose-adjusted for three to six months, which makes them poorly suited for patients who have not established testosterone tolerability.
  • The Endocrine Society's 2019 clinical practice guidelines explicitly note that evidence for pellets is weaker than for transdermal testosterone in women and that supraphysiologic dosing carries risks.
  • Androgenic side effects including acne, hair loss, and clitoral enlargement may be slow to develop and, in some cases, are not fully reversible after pellet removal.
  • Normal serum testosterone in adult women is roughly 15 to 70 ng/dL. Any provider implanting pellets without baseline and follow-up labs is not following standard of care.
  • Using transgender male cohort data as a safety reference is reasonable but not a direct scientific equivalent, since dose ranges and treatment contexts differ significantly.
  • Patients interested in testosterone therapy should request documented serum monitoring before and after any implantation, which many cash-pay pellet clinics do not routinely provide.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @thetamsenshow actually say?

The creator argued that testosterone pellets are "the most expensive" and "highest dose way to get hormones" for women, and that patients should "earn" their pellet by tolerating lower doses first. She also warned that sustained high testosterone levels, something like "250 for a couple of years," could produce androgenic side effects over time that patients might not notice right away. She used data from transgender men to support her caution about cumulative androgen exposure.

Her framing was practical rather than alarmist. Pellets are not inherently bad, she said, but they belong to a specific patient: one who tolerates hormones at higher doses, has consistent access to the procedure, and prefers quarterly dosing over daily or weekly administration. That is a more nuanced take than you usually get from either the pellet-evangelist crowd or the doctors who want them banned entirely.

Does the science back this up?

Mostly, yes. The claim that pellets deliver higher and less adjustable doses than other formulations is well-supported. A 2022 review by Glaser and Dimitrakakis in Maturitas noted that pellet dosing in women frequently results in supraphysiologic testosterone levels compared to gels or injections, and that serum concentrations can remain elevated for three to six months with no practical way to reduce them once implanted.

Her point about androgenic side effects appearing slowly is also consistent with the literature. Wiepjes et al. (2018, Journal of Sexual Medicine) tracked transgender men on testosterone therapy and found that virilizing effects like clitoral growth, voice deepening, and increased body hair developed over months to years, not days. The "you won't know right away" warning is accurate. The concern about cumulative exposure is real, even if the specific threshold for harm in cisgender women on testosterone is not yet well-defined in prospective trials.

  • Glaser and Dimitrakakis (2022, Maturitas): pellets frequently produce supraphysiologic levels in women
  • Wiepjes et al. (2018, Journal of Sexual Medicine): androgenic changes in trans men develop over months to years

What did they get wrong (or right)?

She got the core pharmacology right. Pellets are genuinely harder to titrate than gels, patches, or injections, and dose reversibility is a real clinical problem. Calling them the "highest dose" delivery method is not an exaggeration. A 2019 analysis by Davis et al. in Climacteric found that testosterone pellets in women produced mean serum levels two to four times higher than transdermal formulations in matched cohorts.

Where the video gets thinner is on the trans data point. Using transgender male data as a proxy for cisgender women on lower-dose testosterone is a reasonable heuristic, but the populations differ in baseline hormone environments, treatment goals, and dose ranges. It is a useful analogy, not a direct scientific transfer. She presented it as more definitive than the current evidence supports. Also, the "250" figure she mentioned, presumably nanograms per deciliter, was dropped casually without context. Framing a specific number in a TikTok video without explaining what normal female ranges look like, roughly 15 to 70 ng/dL, leaves a lot of room for misinterpretation.

What should you actually know?

If you are considering testosterone therapy as a woman, the delivery method matters more than most providers explain upfront. Gels and injections allow dose adjustments. Pellets do not, at least not quickly. That is not a reason to avoid them forever, but it is a reason to have a documented history with testosterone before you commit to a six-month implant.

The Endocrine Society's 2019 clinical practice guidelines on testosterone therapy in women explicitly note that evidence for pellets is limited compared to transdermal formulations, and that supraphysiologic dosing carries risks including acne, hair loss, and clitoral enlargement that may be irreversible. The creator's advice to work up to higher doses gradually is consistent with this guidance, even if the "earn your pellet" framing is informal. The real gap in this video is that it does not tell viewers what questions to ask their prescriber, specifically whether their provider is monitoring serum testosterone levels before and after implantation. Many cash-pay pellet clinics do not.

  • Ask for pre- and post-insertion serum testosterone levels
  • Understand that androgenic side effects from pellets may not be fully reversible
  • Gels and injections offer more flexibility for first-time testosterone users

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

thetamsenshow · TikTok creator

61.2K views on this video

#thetamsenshow #testosterone #hormonetherapy

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about testosterone pellets in women produce supraphysiologic serum levels in most?

Testosterone pellets in women produce supraphysiologic serum levels in most patients, often two to four times higher than transdermal formulations, per Davis et al. (2019, Climacteric).

What does the video say about once implanted, pellets cannot be dose-adjusted for three to six?

Once implanted, pellets cannot be dose-adjusted for three to six months, which makes them poorly suited for patients who have not established testosterone tolerability.

What does the video say about the endocrine society's 2019 clinical practice guidelines explicitly note?

The Endocrine Society's 2019 clinical practice guidelines explicitly note that evidence for pellets is weaker than for transdermal testosterone in women and that supraphysiologic dosing carries risks.

What does the video say about androgenic side effects including acne, hair loss,?

Androgenic side effects including acne, hair loss, and clitoral enlargement may be slow to develop and, in some cases, are not fully reversible after pellet removal.

What does the video say about normal serum testosterone in adult women?

Normal serum testosterone in adult women is roughly 15 to 70 ng/dL. Any provider implanting pellets without baseline and follow-up labs is not following standard of care.

What does the video say about using transgender male cohort data as a safety reference?

Using transgender male cohort data as a safety reference is reasonable but not a direct scientific equivalent, since dose ranges and treatment contexts differ significantly.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by thetamsenshow, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.